Assessing the safety and feasibility of a new cutaneous ureterostomy suture approch (flap embedding approch ) after radical cystectomy :protocol for an open label, single-center, phase I clinical trial

Author:

Yu Xufeng1,Chen Qing1,Ying Yidie1,Wang Maoyu1,Wang Ziwei1,Zhang Chen1,Wang Yi1,He Wei1,Wang Yue1,Yang Xuncheng1,Xie Jiaxin1,Xu Chuanliang1,Hua Meimian1,Zeng Shuxiong1

Affiliation:

1. Changhai Hospital

Abstract

Abstract Introduction: Choosing the appropriate urinary diversion method has always been a challenging decision for patients undergoing radical cystectomy (RC). Emerging data suggests that cutaneous ureterostomy (CU) has advantages over ileal conduit (IC) and orthotopic neobladder (ONB) in terms of reduced operation time, blood loss, and perioperative complications. However, traditional CU is associated with a high incidence of stoma stenosis (>50% or more). To address this issue, we have developed a new suture approach called CU-flap embedding approach. In this trial, we aim to investigate the incidence rate of ureteral stoma stenosis and other related complications associated with flap embedding approach. The goal is to determine whether the flap embedding approach is a safe and feasible suture technique. Methods and analysis:This study is a phase I, open-label study to investigate the safety and feasibility of the new suture approch of CU-flap embedding approch. Patients with indications for RC will be recruited. All enrolled patients will be sutured CU by flap embedding approch after RC. The primary objective is the incidence of ureteral stoma stenosis, the secondary objective is the incidence of other postoperative related complications of the approch. The postoperative complications will be assessed by Clavien-Dindo classification of surgical complications. Ethics and dissemination:This protocol was approved by the Institutional Review Board of Shanghai Changhai Hospital (ref. CHEC2023-107). The study will be performed in compliance with applicable local legislation and in accordance with the ethical principles developed by the World Medical Association in the Declaration of Helsinki 2013. Study results will be disseminated through conferences and peer-reviewed scientific journals. Trial registration number:ChiCTR2300073003

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3